CN Patent

CN1575795A — 盐酸纳洛酮鼻腔喷雾剂

Assigned to Institute of Pharmacology and Toxicology of AMMS · Expires 2005-02-09 · 21y expired

What this patent protects

本发明涉及盐酸纳洛酮的鼻腔喷雾剂及制备方法，本发明制剂可以单剂量及多剂量形式使用。本发明喷雾剂包括盐酸纳洛酮、渗透压调节剂、防腐剂、渗透促进剂及水。

USPTO Abstract

本发明涉及盐酸纳洛酮的鼻腔喷雾剂及制备方法，本发明制剂可以单剂量及多剂量形式使用。本发明喷雾剂包括盐酸纳洛酮、渗透压调节剂、防腐剂、渗透促进剂及水。

Drugs covered by this patent

naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.

Patent Metadata

Patent number: CN1575795A
Jurisdiction: CN
Classification: —
Expires: 2005-02-09
Drug substance claim: No
Drug product claim: No
Assignee: Institute of Pharmacology and Toxicology of AMMS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.